Adjuvant chemoradiotherapy in patients (pts) with resectable gastric (GC) or gastroesophageal junction cancer (GEJC): A monoinstitutional experience

被引：0
|
作者：
Soini, Barbara
Pani, Giuseppe
Caffo, Orazio
Frisinghelli, Michela
Veccia, Antonello
Brugnara, Sonia
Caldara, Alessia
DiPasquale, MariaChiara
Ferro, Antonella
Mussari, Salvatore
Murgia, Viviana
Russo, Lucianna
Valduga, Francesco
Tumulo, Salvatore
Galligioni, Enzo
机构：
[1] Med Oncol Santa Chiara Hosp, Trento, Italy
[2] Radiotherapy Santa Chiara Hosp, Trento, Italy
[3] Santa Maria degli Angeli Hosp, Pordenone, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14711
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Concurrent chemoradiotherapy (cCTRT) with weekly cisplatin (wCDDP) in locally advanced cervical cancer (LACC) patients (pts): a monoinstitutional experience
    Murgia, V.
    Caffo, O.
    Caldara, A.
    Brugnara, S.
    Dipasquale, M.
    Ferro, A.
    Frisinghelli, M.
    Macrini, S.
    Maines, F.
    Daniela, M.
    Trentin, C.
    Valduga, F.
    Veccia, A.
    Galligioni, E.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 34 - 35
  • [32] Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
    Anderegg, M. C. J.
    van der Sluis, P. C.
    Ruurda, J. P.
    Gisbertz, S. S.
    Hulshof, M. C. C. M.
    van Vulpen, M.
    Mohammed, N. Haj
    van Laarhoven, H. W. M.
    Wiezer, M. J.
    Los, M.
    Henegouwen, M. I. van Berge
    van Hillegersberg, R.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (08) : 2282 - 2290
  • [33] HER2 AND OTHER BIOMARKER TESTING PATTERNS AMONG PATIENTS WITH ADVANCED GASTRIC CANCER (GC) OR GASTRIC ESOPHAGEAL JUNCTION CANCER (GEJC)
    Mehta, S.
    Herms, L.
    Chou, L. N.
    Lam, C. K.
    Kwong, W. J.
    Cosgrove, D.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S497 - S497
  • [34] NUMBER NEEDED TO TREAT ANALYSIS OF NIVOLUMAB VERSUS SURVEILLANCE FOR THE ADJUVANT TREATMENT OF PATIENTS WITH RESECTED ESOPHAGEAL CANCER (EC) OR GASTROESOPHAGEAL JUNCTION CANCER (GEJC)
    Singh, P.
    Kassahun, S.
    Toor, K.
    Kim, I
    Kakehi, S.
    Estella-Perez, E.
    Venkatachalam, M.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S387 - S387
  • [35] Phase II pharmacokinetic (PK) and pharmacodynamic (PD) study of OSI-7904L in previously untreated patients (pts) with advanced gastric or gastroesophageal junction cancer (G/GEJC).
    Falk, SJ
    Anthoney, A
    Eatock, M
    van Cutsem, E
    Evans, J
    Valle, J
    Chick, J
    Drolet, D
    Ferry, D
    Ajani, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 318S - 318S
  • [36] First-line immunochemotherapy modulates peripheral immune landscape in advanced gastric cancer and gastroesophageal junction cancer (GC/GEJC): Prediction of response to combination therapy
    Wu, Hao
    Meng, Enqing
    Li, Ping
    Jiang, Rongqi
    Cheng, Xu
    Zhu, Chan
    Zhang, Xing
    Chen, Dongsheng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Total neoadjuvant chemotherapy with FOLFIRINOX regimen in patients with resectable locally advanced gastric and gastroesophageal junction cancer
    Sedova, M. V.
    Batov, M. A.
    Kolomeytseva, A. A.
    Khomyakov, V. M.
    Volchenko, N. N.
    Fedenko, A. A.
    Kaprin, A. D.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S881 - S881
  • [38] Real-world (RW) effectiveness of nivolumab plus chemotherapy (NIVO plus chemo) in patients (pts) with advanced or metastatic gastric carcinoma, gastroesophageal junction carcinoma, or esophageal adenocarcinoma (GC/GEJC/EAC)
    Chau, Ian
    Barzi, Afsaneh
    Zhang, Ying
    You, Min
    Bertwistle, David
    Davis, Catherine
    Chen, Clara
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 295 - 295
  • [39] Understanding treatment, utilization, and costs in advanced/metastatic (Adv/Met) gastric or gastroesophageal junction cancer (GC/GEJC): Implications for episodic payment models.
    Kelly, Ronan Joseph
    Le, Hannah
    Wu, Sze-Jung
    Laurie, Melissa
    Raval, Amit D.
    Shi, Qian
    Korytowsky, Beata
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): 14-month follow-up of CheckMate 577
    Moehler, M.
    Ajani, J. A.
    Kuzdzal, J.
    Zander, T.
    Van Cutsem, E.
    Piessen, G.
    Mendez, G.
    Feliciano, J.
    Motoyama, S.
    Lievre, A.
    Uronis, H.
    Elimova, E.
    Grootscholten, C.
    Geboes, K.
    Zhang, J.
    Soleymani, S.
    Lei, M.
    Kondo, K.
    Cleary, J.
    Kelly, R. J.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1045 - S1046
12345